Article

Gregory J. Riely on the Identification and Treatment of MET Exon 14 Skipping Mutations

Author(s):

Gregory J. Riely

Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.

Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.

Related Videos
Image of a man with short black hair.
Image of man with black hair.
Image of a woman with tied back hair, wearing pearl earrings.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Image of man with gray hair.
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Image of a man with white hair and a white goatee.
Image of a woman with brown wavy hair, wearing a navy blue top.
Related Content
Image of a heart monitor.
October 22nd 2024

Identifying Cardiovascular Disease Risk in Cancer Survivors

Spencer Feldman
The risk of cardiovascular disease is elevated in cancer survivors, regardless of treatment, and is influenced by cancer type and treatment-related factors.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Illustration of doctor pointing at lung.
October 17th 2024

Incidence of Cardiovascular Disease May Increase in Older Adults With Cancer

Spencer Feldman
Aspirin did not impact CVD incidence; however, risk may be higher in those with metastatic, hematological and lung cancer and following chemotherapy.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Image of a person receiving radiation therapy.
October 10th 2024

SBRT, CRT Radiation Therapies May Not Have Many Differences for NSCLC

Ashley Chan
Two radiation therapy techniques, SBRT and hypofractionated CRT, may not have many differences for patients with stage 1 NSCLC, but limitations matter.
Illustration of a woman with shoulder length hair, wearing round glasses.
October 10th 2024

I Still Reflect on My Lung Cancer Treatment Decisions

Sue McCarthy
When I was diagnosed with lung cancer, I didn’t want to receive chemotherapy, especially when I was a good candidate for immunotherapy.